MedTrace Logo

Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms

NCT05402046 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 605

Last updated 2022-06-02

No results posted yet for this study

Summary

A Multicenter, Prospective, Low-interventional Clinical Study Evaluating on mobile application validation ("ProRodinki") in assessing the risk of skin malignant neoplasms

Conditions

Interventions

OTHER

Mobile phone application "ProRodinki"

Patient were underwent photography using mobile phone and tested application "ProRodinki"just before preplanned excisional or incisional biopsy. Application AI result than will be compared with pathology report by independent investigator

Sponsors & Collaborators

  • Privolzhsky Research Medical University

    collaborator OTHER

  • MelanomaPRO, Russia

    lead OTHER

Principal Investigators

  • Lev V Demidov, Professor · The Russian Melanoma Professional Association (Melanoma.PRO)

  • Igor V Samoylenko · The Russian Melanoma Professional Association (Melanoma.PRO)

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-23
Primary Completion
2023-04-30
Completion
2024-04-30

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05402046 on ClinicalTrials.gov